Contract awardedQuality management system (QMS) software

eQMS for Cell and Gene Therapy Catapult stays with Ideagen

Cell and Gene Therapy Catapult renewed its subscription to Ideagen's electronic quality management system (eQMS). Ideagen keeps the work, which covers continued access to the hosted platform plus maintenance and support.

The Catapult awarded the renewal directly, without a competition, in July 2026. The two-year contract is worth £120,598, or £144,717 including VAT, and runs to August 2028.

Alert me to similar tenders

Contract ends August 2028

What
Quality management system (QMS) software
Supplier
Ideagen
Value
£120,598
How it was bought
Below threshold - without competition
Dates and next
Aug 2026 to Aug 2028

How it was bought

3 official notices
  1. 29 Jul 2026Award noticeFind a Tender
  2. 11 Aug 2026Award noticeFind a Tender
  3. 31 Aug 2026Contract starts
  4. 1 Sep 2026Award noticeFind a Tender
  5. 30 Aug 2028Contract ends

Cell and Gene Therapy Catapult has bought this twice since 2021

Last bought
Jul 2026
Typical length
1.5 years
Typical value
£119,952
Suppliers used
2
AwardedContractWon byValue
Jul 2026This purchase2 yearsIdeagen£120,598
Apr 2024Locked1 yearLocked£119,307

Suppliers Cell and Gene Therapy Catapult has used

SupplierContractsValue
Ideagen Won this one1£120,598
Locked1£119,307
See the contracts and who won them

Figures to 21 November 2026

How it compares

With every quality management system (QMS) software award since 2021

Half of awards fall between £27,000 and £111,615Median £61,610

Awards
114
Firms that won them
28
Median award
£61,610
of 110 with a value
This award
Bigger than 78%
of them
Typical length
2 years
In London
21 awards

Ideagen ranks 1st of 28 firms for quality management system (QMS) software awards since 2021.

RankFirmAwardsValue
1Ideagen Won this one70£5.39m
2Locked5£298,817
3Locked4£45,331
4Locked3£305,100
4Locked3£194,566
6Locked2£474,174
See who wins this work

Quality management system (QMS) software at other buyers

Cell and Gene Therapy Catapult has awarded 121 contracts since 2021.

See Cell and Gene Therapy Catapult's page